Advanced search×

Treatment of septic common digital extensor tenosynovitis by complete resection in seven horses.

Todd M TM Booth, John J Abbot, Antony A Clements, Ellen R ER Singer, and Peter D PD Clegg

Vet Surg 33(2):107-11 (2004) PMID 15027971

To describe and evaluate a technique for radical resection of the entire intrathecal component of the common digital extensor tendon (CDET) in horses.

DOI: 10.1111/j.1532-950X.2004.04017.x
Version: za2963e q8zaf q8zb8 q8zca q8zd3 q8ze9 q8zf0 q8zg2
Buy PDF

Similar articles you may find interesting…

  1. A narrative review of factors influencing detection and treatment of depression in Vietnam.
    Maria Niemi, Mats Målqvist, and Torkel Falkenberg

    Int J Ment Health Syst 7(1):15 (2013) PMID 23647977

    We conducted a narrative review of research literature on factors that influence depression screening, diagnosis and treatment among the Vietnamese population. This explorative approach included studies describing: a) culturally or contextually specific risk-factors for depression; b) any depression...
    PDF not found
  2. Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy.
    Seung-Gu Yeo, Min-Jeong Kim, and Jae Hwan Oh

    Radiat Oncol 8(1):114 (2013) PMID 23647920

    This study showed that LARC patients receiving pre-operative CRT tended to develop late LR more often than those receiving post-operative CRT. Further extended follow-up than is conventional may be necessary in LARC patients who are managed with optimized multimodal treatments, and the follow-up str...
    PDF not found
  3. A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic ...
    Hope S Rugo, Mario Campone, and Xavier Pivot

    Breast Cancer Res Treat (2013) PMID 23649189

    The aim of this phase II trial was to estimate the objective response rate (ORR) of two different schedules of ixabepilone [weekly or every 3 weeks (Q3W)] combined with bevacizumab, relative to a reference arm of weekly paclitaxel and bevacizumab. Patients with human epidermal grow...
    Buy PDF